
Javier Gómez Arbonés
Grado: Doctor/a
973 702 208
xavier.gomez(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/C-1212-2009
Grupos
Publicaciones
-
Huguet-Feixa, A; Artigues-Barberà, E; Sol, J; Gomez-Arbones, X; Godoy, P; Bravo, MO
Vaccine refusal and hesitancy in Spain: an online cross-sectional questionnaire
Bmc Primary Care 26 -. .
-
Muñoz-Santa, A; López-Causapé, C; Bellés, A; Gómez-Arbonés, X; Cortés-Lara, S; García-González, M; Pifarré-Teixidó, R; Oliver, A
Pseudomonas aeruginosa chronic infections in patients with bronchiectasis: a silent reservoir of carbapenemase-producing epidemic high-risk clones
Jac-Antimicrobial Resistance 7 -. .
-
Pilares Ortega E; Colomina Morales J; Gómez Arbonés J; Drudis Morrell R; Torra Riera M
Determining factors on length of stay in primary total knee arthroplasty patients using enhanced recovery protocol after surgery (ERAS) pathway.
Revista Española De Cirugía Ortopédica Y Traumatología 68 446-453. .
-
Matas-Nadal, C; Gatius, S; Ribes-Santolaria, M; Guasch-Vallés, M; Arbones, XG; Casanova, JM; Aguayo-Ortiz, RS; Gari, E
FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness
ARCHIVES OF DERMATOLOGICAL RESEARCH 316 342-342. .
-
Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; Gómez CT; Garí E; Aguayo-Ortiz RS
Biomarkers found in the tumor interstitial fluid may help explain the differential behavior among keratinocyte carcinomas.
MOLECULAR & CELLULAR PROTEOMICS 22 100547-100547. .
-
Fuertes Abardía C; Ballesta Juan P; Cruz Esteve I; Galindo Ortego G; Marsal Mora JR; Gómez-Arbonés X
Prescripción potencialmente inadecuada: utilidad de los criterios STOPP/START versión 2 a nivel poblacional en Cataluña.
MEDICINA DE FAMILIA-SEMERGEN 48 163-173. .
-
Matas-Nadal, C; Sagrista, M; Gomez-Arbones, X; Sobrino Bermejo C; Fernandez-Armenteros, JM; Àngel Baldó J; Casanova Seuma JM; Aguayo Ortiz R
Risk factors for early-onset basal cell carcinomas and the trend towards their female predominance.
Journal Der Deutschen Dermatologischen Gesellschaft 19 364-371. .
-
Matas-Nadal C; Sagristà M; Gómez-Arbonés X; Sobrino Bermejo C; Fernández-Armenteros JM; Àngel Baldó J; Casanova Seuma JM; Aguayo Ortiz R
Risikofaktoren für Basalzellkarzinome in jungem Alter und Trend zur Prädominanz bei Frauen.
Journal Der Deutschen Dermatologischen Gesellschaft 19 364-372. .
-
Bellés-Bellés A; Bernal M; Gómez-Arbonés J; Bernet A; Picó S; Bueno J; Chávez C; García-González M; Ibarz M
E-gene RT-PCR Crossing Point Value and Other Biochemical Parameters as Useful Markers of Death Risk in COVID-19 Patients.
ejournal International Federation of Clinical Chemistry and Laboratory Medicine 32 98-104. .
-
Lopez-Cano, C; Gutierrez-Carrasquilla, L; Sanchez, E; Gonzalez, J; Yeramian, A; Marti, R; Hernandez, M; Cao, G; Ribelles, M; Gomez, X; Barril, S; Barbe, F; Hernandez, C; Simo, R; Lecube, A
Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes
Frontiers in Endocrinology 10 752-752. .
-
Revuelto Artigas T; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñe Espinet JM; Betriu Bars A
Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis
REVISTA CLINICA ESPANOLA 219 293-302. .
-
Fernandez-Armenteros, JM; Gomez-Arbones, X; Buti-Sole, M; Betriu-Bars, A; Sanmartin-Novell, V; Ortega-Bravo, M; Martinez-Alonso, M; Casanova-Seuma, JM
Epidemiology of Psoriasis. A Population-Based Study.
ACTAS DERMO-SIFILIOGRAFICAS 110 385-392. .
Proyectos
- Development of a simulation environment as a tool to support the design of studies and clinical trials.
- Diabetes mellitus tipo 2 y activación simpática durante el sueño